• Vaccine sales power Pfizer through first quarter

    2 days ago - By Finance Commerce

    Pfizer, buoyed by a huge jump in sales for its COVID-19 vaccine and solid performance across most of the company, is hiking its 2021 financial forecast sharply after blowing past Wall Street expectations for the first quarter.
    Read more ...

     

  • Pfizer's posts $4.9B 1Q profit as vaccine strategy pays off

    2 days ago - By Chron

    Selling vaccines during a pandemic has boosted Pfizer's bottom line and proven that a strategy it embarked upon over a decade ago is now paying off handsomely.
    The New York-based pharmaceutical giant reported Tuesday that it earned $4.9 billion in the first three months of the year and it dramatically raised its profit forecast for all of 2021 thanks to strong demand for its COVID-19 vaccine. The company, along with its German partner BioNTech, anticipate strong revenue from the vaccine and booster shots for the next three years.
    Once viewed as a marketing machine for blockbuster...
    Read more ...

     

  • Pfizer's long range vaccine pursuits pay off

    Pfizer's long range vaccine pursuits pay off

    2 days ago - By Stl Today

    Pfizer, buoyed by a huge jump in sales for its COVID-19 vaccine and solid first-quarter performance across most of the company, hiked its 2021 financial forecast after sharply after blowing past Wall Street expectations.
    Read more ...